Investor Relations

SEC Filings

Document Details

Form
Filing Date
Sep 17, 2024
Document Date
Jun 15, 2024
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.